Loading ...

PLLeu- PLL(DMA)-Tat(SA) nanoparticles

Based on

1 Articles
2015 Most recent source

Composition

1

poly (propargyl-terminated SA-modified poly(L-lysine)/propargyl-terminated SA-modified poly(L-lysine)/poly(L-leucine)/poly(L-leucine))

Type Polymer
Formula
Role core
2

azido-terminated Tat peptide

N3-Tat(SA)
Type Biomolecule
Formula
Role layer

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
critical micelle concentration dependent on pH

More information available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information/entries available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
HeLa cells

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  • propargyl-terminated poly(L-lysine)-block-poly(L-leucine)
  • azido-terminated Tat peptide
  1. Bqscoy35ywO1ERJt
Product

PLLeu- PLL(DMA)-Tat(SA) nanoparticles

Size: not specified

Medium/Support: none

Method 2

Type: Chemical synthesis
Source:
  1. 2aRkeorwL8NkMn1A3QcHOSZJ9EMQ25cym9D7Xf
Product

PLLeu- PLL(DMA)-Tat(SA) nanoparticles

Size: not specified

Medium/Support: none

Method 3

Type: Chemical synthesis
Source:
Starting materials
  1. jjmEyu436nN53ueG
  2. 4pKU
  3. mIKZ7
Product

PLLeu- PLL(DMA)-Tat(SA) nanoparticles

Diameter: 20 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial